Yellow fever revaccination during infliximab therapy.
Scheinberg
Morton
M
Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Guedes-Barbosa
Luis Sergio
LS
Mangueira
Cristovao
C
Rosseto
Eliane Aparecida
EA
Mota
Licia
L
Oliveira
Ana Cristina
AC
Lima
Rodrigo Aires
RA
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000150:complications / Q000188:drug therapy; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007117:Immunization, Secondary / Q000379:methods; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D015004:Yellow Fever / Q000097:blood / Q000150:complications / Q000517:prevention & control*; D022341:Yellow Fever Vaccine / Q000097:blood / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D022341:Yellow Fever Vaccine; D000069285:Infliximab